Anales Oftalmológicos

59 / 64

1. Seabra MC, Mule s EH, Hume AN. Rab
GTPases, intracellular traffic and disease.
Trends Mol Med. 2002;8(1):23-30.
2. Ma cDona l d IM , Ru s s e ll L , Chan CC .
Choroideremia: new findings from ocular
pathology and review of recent literature.
Surv Ophthalmol. 2009;54(3):401-407.
3. van Bokhoven H, Schwartz M, Andre´asson S,
et al. Mutation spectrum in the CHM gene of
Danish and Swedish choroideremia patients.
Hum Mol Genet. 1994;3(7):1047-1051.
4. Syed N, Smith JE, John SK, Seabra MC, Aguirre GD,
Milam AH. Evaluation of retinal photoreceptors and
pigment epithelium in a female carrier of choroideremia.
Ophthalmology.2001;108(4):711-720.
5. Potter MJ, Wong E, Szabo SM, McTaggart
KE. Clinical findings in a carrier of a new
mu t a t i on in t he cho r o i d e r emia gene .
Ophthalmology. 2004;111(10):1905-1909.
6. Renner AB, Fiebig BS, Cropp E, Weber BH, Kellner
U. Progression of retinal pigment epithelial alterations
during long-term follow-up in female carriers of
choroideremia and report of a novel CHMmutation.
Arch Ophthalmol. 2009;127(7):907-912.
7. Renner AB, Kellner U, Cropp E, e t al.
Choroideremia: variability of clinical and
elec trophysiological charac teristics and
first report of a negative electroretinogram.
Ophthalmology. 2006;113(11):2066-2073, e1-e10.
8. Pereira-Leal JB, Hume AN, Seabra MC.
Prenylation of Rab GTPases: molecular
mechanisms and involvement in genetic disease.
FEBS Lett. 2001;498(2-3):197-200.
9. A l o r y C , Ba l ch WE . Or g an i z a t i on o f
t h e R a b - GD I / CHM s u p e r f am i l y : t h e
functional basis for choroideremia disease.
Traffic. 2001;2(8):532-543.
10. Sergeev YV, Smaoui N, Sui R, et al. The functional
effect of pathogenic mutations in Rab escort protein 1.
Mutat Res. 2009;665(1-2):44-50.
11. van den Hurk JA, Hendriks W, van de Pol DJ,
et al. Mouse choroideremia gene mutation
causes photoreceptor cell degeneration and is
not transmitted through the female germline.
Hum Mol Genet. 1997;6(6):851-858.
12. Bainbridge J, Smith A, Barker S, Robbie
S, et al. Effect of Gene Therapy on Visual
Function in Leber´s Congenital Amaurosis.
N Engl J Med 2008; 358:2231-2239.
13. van den Hurk JA, Schwartz M, van Bokhoven H, et al.
Molecular basis of choroideremia (CHM): mutations
involving the Rab escort protein-1 (REP-1) gene.
Hum Mutat. 1997;9(2):110-117
Autor para correspondencia,
Correo electrónico:
BIBLIOGRAFÍA
59
aso línico oroideremia presentación clínica y perspe ivas futuras
el EPR.12 Si bien CHR es una entidad rara,
las implicancias en el tratamiento de otras
enfermedades más comunes como retinitis
pigmentosa (1 en 3 mil pacientes) o incluso
DMRE (1 en 4 pacientes sobre 75 años) son
enormes.
Conflicto de intereses
El autor declara no tener ningún conflicto
de interés.